- Home
- LGVN vs SOND Comparison
LGVN vs SOND Comparison
Compare LGVN & SOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- SOND
- Stock Information
- Founded
- LGVN 2014
- SOND 2014
- Country
- LGVN United States
- SOND United States
- Employees
- LGVN N/A
- SOND N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- SOND Hotels/Resorts
- Sector
- LGVN Health Care
- SOND Consumer Discretionary
- Exchange
- LGVN Nasdaq
- SOND Nasdaq
- Market Cap
- LGVN 23.4M
- SOND 23.2M
- IPO Year
- LGVN 2021
- SOND N/A
- Fundamental
- Price
- LGVN $1.56
- SOND $2.21
- Analyst Decision
- LGVN Strong Buy
- SOND
- Analyst Count
- LGVN 3
- SOND 0
- Target Price
- LGVN $8.67
- SOND N/A
- AVG Volume (30 Days)
- LGVN 827.1K
- SOND 117.0K
- Earning Date
- LGVN 08-13-2025
- SOND 07-23-2025
- Dividend Yield
- LGVN N/A
- SOND N/A
- EPS Growth
- LGVN N/A
- SOND N/A
- EPS
- LGVN N/A
- SOND N/A
- Revenue
- LGVN $2,225,000.00
- SOND $621,272,000.00
- Revenue This Year
- LGVN N/A
- SOND $28.50
- Revenue Next Year
- LGVN $51.48
- SOND $17.62
- P/E Ratio
- LGVN N/A
- SOND N/A
- Revenue Growth
- LGVN 127.50
- SOND 3.19
- 52 Week Low
- LGVN $1.14
- SOND $0.88
- 52 Week High
- LGVN $4.29
- SOND $10.50
- Technical
- Relative Strength Index (RSI)
- LGVN 58.78
- SOND 42.07
- Support Level
- LGVN $1.43
- SOND $2.10
- Resistance Level
- LGVN $1.80
- SOND $3.02
- Average True Range (ATR)
- LGVN 0.12
- SOND 0.20
- MACD
- LGVN 0.01
- SOND -0.10
- Stochastic Oscillator
- LGVN 58.62
- SOND 10.23
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About SOND Sonder Holdings Inc.
Sonder Holdings Inc is engaged in providing short and long-term accommodations to travelers in various cities across North America, Europe, and the Middle East. The Sonder units in each apartment-style building and each hotel property are selected, designed, and managed directly by the Company. The Company generates revenues by providing short-term or month-to-month accommodations to its guests. The Company also provides accommodations to travelers through boutique hotels.